Drawing for USYMTRA

USPTO serial 86659989

USYMTRA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
COLLOPY, DIANE PATRICIA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with USYMTRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidismACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 4, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 4, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 28, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 27, 2018EX5GSOU EXTENSION 5 GRANTED
Jun 14, 2018EXT5SOU EXTENSION 5 FILED
Jun 14, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 3, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 5, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 1, 2017EX4GSOU EXTENSION 4 GRANTED
Dec 1, 2017EXT4SOU EXTENSION 4 FILED
Dec 1, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 8, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 7, 2017EX3GSOU EXTENSION 3 GRANTED
Jul 7, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 28, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 12, 2017EXT3SOU EXTENSION 3 FILED
Jun 12, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 30, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 16, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 15, 2016EX2GSOU EXTENSION 2 GRANTED
Nov 15, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 31, 2016EXT2SOU EXTENSION 2 FILED
Oct 31, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 28, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 24, 2016EX1GSOU EXTENSION 1 GRANTED
Jun 24, 2016EXT1SOU EXTENSION 1 FILED
Jun 24, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 29, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 3, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 3, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 14, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 21, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 21, 2015DOCKASSIGNED TO EXAMINER
Jun 16, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 15, 2015NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance